Penumbra (PEN) Income from Continuing Operations (2014 - 2026)
Penumbra (PEN) reported Income from Continuing Operations of 32588000.0 for Q1 2026, down 16.99% year-over-year from 39258000.0 in Q1 2025, and down 31.09% quarter-over-quarter from 47294000.0 in Q4 2025.
Penumbra (PEN) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Income from Continuing Operations data on file, last reported at 32588000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 32588000.0, down 16.99% year-over-year; the trailing twelve-month figure through Mar 2026 was 170977000.0 (up 304.73% YoY), and the FY2025 annual result was 177687000.0, up 1168.11% from the prior year.
- Income from Continuing Operations declined to 32588000.0 in Q1 2026 per PEN's latest filing, from 47294000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 54218000.0 in Q4 2023 and troughed at 60174000.0 in Q2 2024.
- A 5-year average of 18422352.94 and a median of 18960000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations jumped 10725.32% in 2023, then plunged 417.37% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 3877000.0 in 2022, then surged by 1298.45% to 54218000.0 in 2023, then tumbled by 37.87% to 33683000.0 in 2024, then soared by 40.41% to 47294000.0 in 2025, then slumped by 31.09% to 32588000.0 in 2026.
- Business Quant data shows PEN's Income from Continuing Operations at 32588000.0 in Q1 2026, 47294000.0 in Q4 2025, and 45825000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Penumbra | 12.45 Bn | 11.84 Bn | 253.41 Mn | 32.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.59 Mn |
| Dec 31, 2025 | 47.29 Mn |
| Sep 30, 2025 | 45.83 Mn |
| Jun 30, 2025 | 45.27 Mn |
| Mar 31, 2025 | 39.26 Mn |
| Dec 31, 2024 | 33.68 Mn |
| Sep 30, 2024 | 29.48 Mn |
| Jun 30, 2024 | -60.17 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 54.22 Mn |
| Sep 30, 2023 | 9.20 Mn |
| Jun 30, 2023 | 18.96 Mn |
| Mar 31, 2023 | 8.55 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | -3.69 Mn |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | -24.63 Mn |
| Sep 30, 2021 | 8.03 Mn |
| Jun 30, 2021 | 8.30 Mn |